25 XP   0   0   10

Dawnrays Pharmaceutical Holdings Ltd
Buy, Hold or Sell?

Let's analyse Dawnrays together

PenkeI guess you are interested in Dawnrays Pharmaceutical Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dawnrays Pharmaceutical Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dawnrays Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Dawnrays Pharmaceutical Holdings Ltd.

Quick analysis of Dawnrays (30 sec.)










What can you expect buying and holding a share of Dawnrays? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$1.91
Expected worth in 1 year
HK$2.61
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
HK$0.99
Return On Investment
82.6%

For what price can you sell your share?

Current Price per Share
HK$1.20
Expected price per share
HK$1.15 - HK$1.35
How sure are you?
50%

1. Valuation of Dawnrays (5 min.)




Live pricePrice per Share (EOD)

HK$1.20

Intrinsic Value Per Share

HK$-0.24 - HK$1.59

Total Value Per Share

HK$1.67 - HK$3.50

2. Growth of Dawnrays (5 min.)




Is Dawnrays growing?

Current yearPrevious yearGrowGrow %
How rich?$365.3m$331.6m$33.7m9.2%

How much money is Dawnrays making?

Current yearPrevious yearGrowGrow %
Making money$49.5m$49.5m-$16.3k0.0%
Net Profit Margin28.0%30.7%--

How much money comes from the company's main activities?

3. Financial Health of Dawnrays (5 min.)




What can you expect buying and holding a share of Dawnrays? (5 min.)

Welcome investor! Dawnrays's management wants to use your money to grow the business. In return you get a share of Dawnrays.

What can you expect buying and holding a share of Dawnrays?

First you should know what it really means to hold a share of Dawnrays. And how you can make/lose money.

Speculation

The Price per Share of Dawnrays is HK$1.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dawnrays.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dawnrays, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$1.91. Based on the TTM, the Book Value Change Per Share is HK$0.18 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dawnrays.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.032.8%0.032.8%0.032.8%0.032.3%0.022.0%
Usd Book Value Change Per Share0.021.9%0.021.9%0.021.8%0.021.4%0.021.3%
Usd Dividend Per Share0.010.8%0.010.8%0.011.1%0.010.9%0.010.7%
Usd Total Gains Per Share0.032.6%0.032.6%0.042.9%0.032.4%0.022.1%
Usd Price Per Share0.17-0.17-0.21-0.19-0.41-
Price to Earnings Ratio5.15-5.15-6.46-6.80-19.49-
Price-to-Total Gains Ratio5.36-5.36-6.09-6.66-19.31-
Price to Book Ratio0.70-0.70-0.97-0.94-3.11-
Price-to-Total Gains Ratio5.36-5.36-6.09-6.66-19.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.15336
Number of shares6520
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.02
Usd Total Gains Per Share0.030.03
Gains per Quarter (6520 shares)206.59186.34
Gains per Year (6520 shares)826.37745.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1239587816296449735
2479117416425928991480
37181761246888813482225
495823483294118417982970
5119729354120148022473715
6143635224946177626964460
7167641095772207231465205
8191546966598236835955950
9215452837424266440456695
10239458708250295944947440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.00.0100.0%

Fundamentals of Dawnrays

About Dawnrays Pharmaceutical Holdings Ltd

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2024-03-25 16:42:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Dawnrays Pharmaceutical Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dawnrays earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 28.0% means that $0.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 28.0%. The company is making a huge profit. +2
  • The TTM is 28.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.0%TTM28.0%0.0%
TTM28.0%YOY30.7%-2.7%
TTM28.0%5Y28.8%-0.7%
5Y28.8%10Y28.3%+0.5%
1.1.2. Return on Assets

Shows how efficient Dawnrays is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.7% Return on Assets means that Dawnrays generated $0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 9.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.7%TTM9.7%0.0%
TTM9.7%YOY10.7%-1.0%
TTM9.7%5Y10.3%-0.6%
5Y10.3%10Y11.7%-1.4%
1.1.3. Return on Equity

Shows how efficient Dawnrays is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.6% Return on Equity means Dawnrays generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 13.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.6%TTM13.6%0.0%
TTM13.6%YOY15.0%-1.5%
TTM13.6%5Y13.9%-0.3%
5Y13.9%10Y15.3%-1.4%

1.2. Operating Efficiency of Dawnrays Pharmaceutical Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dawnrays is operating .

  • Measures how much profit Dawnrays makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 32.1% means the company generated $0.32  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 32.1%. The company is operating very efficient. +2
  • The TTM is 32.1%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ32.1%TTM32.1%0.0%
TTM32.1%YOY32.7%-0.6%
TTM32.1%5Y35.9%-3.8%
5Y35.9%10Y37.2%-1.3%
1.2.2. Operating Ratio

Measures how efficient Dawnrays is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 1.049. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.049. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.075-0.026
TTM1.0495Y0.887+0.162
5Y0.88710Y0.751+0.136

1.3. Liquidity of Dawnrays Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dawnrays is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.87 means the company has $1.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 1.871. The company is able to pay all its short-term debts. +1
  • The TTM is 1.871. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.871TTM1.8710.000
TTM1.871YOY2.168-0.296
TTM1.8715Y3.076-1.204
5Y3.07610Y3.447-0.371
1.3.2. Quick Ratio

Measures if Dawnrays is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.91 means the company can pay off $1.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 1.913. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.913. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.913TTM1.9130.000
TTM1.913YOY1.684+0.229
TTM1.9135Y2.566-0.653
5Y2.56610Y2.421+0.145

1.4. Solvency of Dawnrays Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dawnrays assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dawnrays to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Dawnrays assets are financed with 28.1% credit (debt) and the remaining percentage (100% - 28.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 0.281. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.281. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.281TTM0.2810.000
TTM0.281YOY0.282-0.001
TTM0.2815Y0.254+0.026
5Y0.25410Y0.239+0.016
1.4.2. Debt to Equity Ratio

Measures if Dawnrays is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 39.0% means that company has $0.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 0.390. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.390. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.390TTM0.3900.000
TTM0.390YOY0.396-0.005
TTM0.3905Y0.345+0.045
5Y0.34510Y0.324+0.021

2. Market Valuation of Dawnrays Pharmaceutical Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dawnrays generates.

  • Above 15 is considered overpriced but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 5.15 means the investor is paying $5.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 4.645. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.148. Based on the earnings, the company is cheap. +2
  • The TTM is 5.148. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.645MRQ5.148-0.503
MRQ5.148TTM5.1480.000
TTM5.148YOY6.462-1.314
TTM5.1485Y6.802-1.654
5Y6.80210Y19.486-12.683
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 7.973. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.837. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.837. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.973MRQ8.837-0.864
MRQ8.837TTM8.8370.000
TTM8.837YOY-234.060+242.897
TTM8.8375Y-35.666+44.503
5Y-35.66610Y-2.586-33.080
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dawnrays is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 0.630. Based on the equity, the company is cheap. +2
  • The MRQ is 0.698. Based on the equity, the company is cheap. +2
  • The TTM is 0.698. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.630MRQ0.698-0.068
MRQ0.698TTM0.6980.000
TTM0.698YOY0.965-0.268
TTM0.6985Y0.938-0.241
5Y0.93810Y3.109-2.171
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dawnrays Pharmaceutical Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1760.1760%0.170+3%0.135+31%0.124+42%
Book Value Per Share--1.9061.9060%1.730+10%1.583+20%1.281+49%
Current Ratio--1.8711.8710%2.168-14%3.076-39%3.447-46%
Debt To Asset Ratio--0.2810.2810%0.2820%0.254+10%0.239+18%
Debt To Equity Ratio--0.3900.3900%0.396-1%0.345+13%0.324+20%
Dividend Per Share--0.0720.0720%0.104-31%0.089-19%0.070+3%
Eps--0.2580.2580%0.2580%0.219+18%0.192+35%
Free Cash Flow Per Share--0.1510.1510%-0.007+105%0.095+58%0.139+8%
Free Cash Flow To Equity Per Share--0.0840.0840%-0.101+220%-0.003+103%0.058+45%
Gross Profit Margin--1.0001.0000%1.0000%0.823+22%0.691+45%
Intrinsic Value_10Y_max--1.589--------
Intrinsic Value_10Y_min---0.237--------
Intrinsic Value_1Y_max--0.144--------
Intrinsic Value_1Y_min--0.044--------
Intrinsic Value_3Y_max--0.444--------
Intrinsic Value_3Y_min--0.074--------
Intrinsic Value_5Y_max--0.758--------
Intrinsic Value_5Y_min--0.040--------
Market Cap1799747942.400-11%1994720636.1601994720636.1600%2504649219.840-20%2232643851.200-11%5103951861.600-61%
Net Profit Margin--0.2800.2800%0.307-9%0.288-3%0.283-1%
Operating Margin--0.3210.3210%0.327-2%0.359-11%0.372-14%
Operating Ratio--1.0491.0490%1.075-2%0.887+18%0.751+40%
Pb Ratio0.630-11%0.6980.6980%0.965-28%0.938-26%3.109-78%
Pe Ratio4.645-11%5.1485.1480%6.462-20%6.802-24%19.486-74%
Price Per Share1.200-11%1.3301.3300%1.670-20%1.458-9%3.212-59%
Price To Free Cash Flow Ratio7.973-11%8.8378.8370%-234.060+2749%-35.666+504%-2.586+129%
Price To Total Gains Ratio4.840-11%5.3645.3640%6.088-12%6.660-19%19.306-72%
Quick Ratio--1.9131.9130%1.684+14%2.566-25%2.421-21%
Return On Assets--0.0970.0970%0.107-9%0.103-6%0.117-17%
Return On Equity--0.1360.1360%0.150-10%0.139-2%0.153-11%
Total Gains Per Share--0.2480.2480%0.274-10%0.224+11%0.194+28%
Usd Book Value--365362383.095365362383.0950%331605904.599+10%308969599.354+18%254840910.800+43%
Usd Book Value Change Per Share--0.0230.0230%0.022+3%0.017+31%0.016+42%
Usd Book Value Per Share--0.2440.2440%0.221+10%0.202+20%0.164+49%
Usd Dividend Per Share--0.0090.0090%0.013-31%0.011-19%0.009+3%
Usd Eps--0.0330.0330%0.0330%0.028+18%0.024+35%
Usd Free Cash Flow--28847513.88328847513.8830%-1367573.346+105%18752059.509+54%28186614.599+2%
Usd Free Cash Flow Per Share--0.0190.0190%-0.001+105%0.012+58%0.018+8%
Usd Free Cash Flow To Equity Per Share--0.0110.0110%-0.013+220%0.000+103%0.007+45%
Usd Market Cap230007787.039-11%254925297.301254925297.3010%320094170.296-20%285331884.183-11%652285047.912-61%
Usd Price Per Share0.153-11%0.1700.1700%0.213-20%0.186-9%0.410-59%
Usd Profit--49516554.70649516554.7060%49532873.2070%42697827.642+16%38211415.396+30%
Usd Revenue--176693684.663176693684.6630%161132058.019+10%148416820.457+19%134927200.884+31%
Usd Total Gains Per Share--0.0320.0320%0.035-10%0.029+11%0.025+28%
 EOD+4 -4MRQTTM+0 -0YOY+18 -175Y+20 -1610Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.645
Price to Book Ratio (EOD)Between0-10.630
Net Profit Margin (MRQ)Greater than00.280
Operating Margin (MRQ)Greater than00.321
Quick Ratio (MRQ)Greater than11.913
Current Ratio (MRQ)Greater than11.871
Debt to Asset Ratio (MRQ)Less than10.281
Debt to Equity Ratio (MRQ)Less than10.390
Return on Equity (MRQ)Greater than0.150.136
Return on Assets (MRQ)Greater than0.050.097
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.888
Ma 20Greater thanMa 501.274
Ma 50Greater thanMa 1001.181
Ma 100Greater thanMa 2001.122
OpenGreater thanClose1.150
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,672,643
Total Liabilities1,030,687
Total Stockholder Equity2,641,956
 As reported
Total Liabilities 1,030,687
Total Stockholder Equity+ 2,641,956
Total Assets = 3,672,643

Assets

Total Assets3,672,643
Total Current Assets1,743,995
Long-term Assets1,928,648
Total Current Assets
Cash And Cash Equivalents 246,387
Short-term Investments 581,357
Net Receivables 208,828
Inventory 241,746
Other Current Assets 2,578
Total Current Assets  (as reported)1,743,995
Total Current Assets  (calculated)1,280,896
+/- 463,099
Long-term Assets
Property Plant Equipment 1,300,869
Goodwill 241,158
Intangible Assets 295,027
Other Assets 66,249
Long-term Assets  (as reported)1,928,648
Long-term Assets  (calculated)1,903,303
+/- 25,345

Liabilities & Shareholders' Equity

Total Current Liabilities932,057
Long-term Liabilities90,719
Total Stockholder Equity2,641,956
Total Current Liabilities
Short-term Debt 6,434
Short Long Term Debt 6,434
Accounts payable 224,073
Other Current Liabilities 700,016
Total Current Liabilities  (as reported)932,057
Total Current Liabilities  (calculated)936,957
+/- 4,900
Long-term Liabilities
Long term Debt Total 444
Other Liabilities 90,275
Long-term Liabilities  (as reported)90,719
Long-term Liabilities  (calculated)90,719
+/-0
Total Stockholder Equity
Common Stock80,389
Capital Surplus 2,911
Other Stockholders Equity 2,561,567
Total Stockholder Equity (as reported)2,641,956
Total Stockholder Equity (calculated)2,644,867
+/- 2,911
Other
Capital Stock80,389
Cash And Equivalents165,295
Cash and Short Term Investments 993,039
Common Stock Shares Outstanding 1,498,789
Liabilities and Stockholders Equity 3,672,643
Net Invested Capital 2,648,390
Net Tangible Assets 2,105,771
Net Working Capital 811,938
Property Plant and Equipment Gross 1,864,067



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
271,837
558,494
687,083
745,053
758,337
851,398
975,215
1,126,465
1,413,157
1,393,816
1,569,643
1,721,148
1,693,400
1,803,736
1,886,364
2,181,211
2,366,029
2,786,387
2,903,735
3,339,558
3,672,643
3,672,6433,339,5582,903,7352,786,3872,366,0292,181,2111,886,3641,803,7361,693,4001,721,1481,569,6431,393,8161,413,1571,126,465975,215851,398758,337745,053687,083558,494271,837
   > Total Current Assets 
171,200
360,141
435,900
473,016
487,506
553,088
608,574
726,227
964,112
822,697
921,891
1,019,185
989,935
1,133,223
1,242,454
1,527,142
1,710,338
1,715,183
1,548,714
1,511,036
1,743,995
1,743,9951,511,0361,548,7141,715,1831,710,3381,527,1421,242,4541,133,223989,9351,019,185921,891822,697964,112726,227608,574553,088487,506473,016435,900360,141171,200
       Cash And Cash Equivalents 
41,475
134,521
98,382
51,948
44,023
76,843
38,936
86,450
210,975
97,805
315,914
462,892
679,047
685,790
663,296
611,077
645,363
471,461
730,986
577,744
246,387
246,387577,744730,986471,461645,363611,077663,296685,790679,047462,892315,91497,805210,97586,45038,93676,84344,02351,94898,382134,52141,475
       Short-term Investments 
828
0
598
867
3,965
4,888
3,404
5,814
55,944
4,707
5,705
5,896
5,440
3,683
7,794
457,743
539,393
645,830
201,192
208,184
581,357
581,357208,184201,192645,830539,393457,7437,7943,6835,4405,8965,7054,70755,9445,8143,4044,8883,9658675980828
       Net Receivables 
0
153,797
245,098
239,505
288,892
341,170
391,041
435,308
499,495
442,989
402,922
381,203
200,062
118,045
225,660
313,214
346,802
370,994
330,747
180,017
208,828
208,828180,017330,747370,994346,802313,214225,660118,045200,062381,203402,922442,989499,495435,308391,041341,170288,892239,505245,098153,7970
       Inventory 
54,592
54,342
84,766
159,836
134,597
124,435
159,536
184,346
181,868
176,010
182,918
155,887
87,581
147,747
124,746
121,133
148,043
180,759
246,028
203,476
241,746
241,746203,476246,028180,759148,043121,133124,746147,74787,581155,887182,918176,010181,868184,346159,536124,435134,597159,83684,76654,34254,592
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
643,910
654,069
655,691
1,071,204
1,355,021
1,828,522
1,928,648
1,928,6481,828,5221,355,0211,071,204655,691654,069643,91000000000000000
       Property Plant Equipment 
49,978
115,914
183,016
243,488
241,610
233,513
301,968
335,885
386,446
506,397
580,889
639,064
639,271
601,537
572,097
530,851
496,841
492,491
659,467
1,034,003
1,300,869
1,300,8691,034,003659,467492,491496,841530,851572,097601,537639,271639,064580,889506,397386,446335,885301,968233,513241,610243,488183,016115,91449,978
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
241,158
241,158
241,158
241,158
241,158241,158241,158241,15800000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,648
29,599
77,440
0
0
0
00077,44029,59943,648000000000000000
       Intangible Assets 
9,135
14,123
13,817
28,549
28,566
37,857
37,709
63,147
61,335
62,984
66,160
60,056
58,071
59,845
65,084
74,882
101,799
149,663
206,716
287,013
295,027
295,027287,013206,716149,663101,79974,88265,08459,84558,07160,05666,16062,98461,33563,14737,70937,85728,56628,54913,81714,1239,135
       Other Assets 
0
68,316
54,350
0
655
26,940
40,166
14,995
14,517
17,900
21,411
18,715
21,262
50,347
31,291
38,778
89,414
131,813
197,064
287,158
66,249
66,249287,158197,064131,81389,41438,77831,29150,34721,26218,71521,41117,90014,51714,99540,16626,940655054,35068,3160
> Total Liabilities 
78,298
183,601
274,896
255,996
245,290
272,392
346,002
414,621
578,203
474,938
587,531
629,411
445,120
329,860
249,608
375,053
444,867
760,075
720,143
941,697
1,030,687
1,030,687941,697720,143760,075444,867375,053249,608329,860445,120629,411587,531474,938578,203414,621346,002272,392245,290255,996274,896183,60178,298
   > Total Current Liabilities 
78,298
183,601
274,896
255,996
245,290
272,392
346,002
403,981
564,526
457,206
562,887
596,351
406,635
284,425
200,656
320,049
320,134
619,322
479,908
697,104
932,057
932,057697,104479,908619,322320,134320,049200,656284,425406,635596,351562,887457,206564,526403,981346,002272,392245,290255,996274,896183,60178,298
       Short-term Debt 
828
0
598
867
3,965
4,888
3,404
5,814
55,944
4,707
5,705
5,896
5,440
3,683
7,794
457,743
539,393
645,830
0
21,013
6,434
6,43421,0130645,830539,393457,7437,7943,6835,4405,8965,7054,70755,9445,8143,4044,8883,9658675980828
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
248,176
188,268
8,847
9,104
0
0
216,776
0
21,013
6,434
6,43421,0130216,776009,1048,847188,268248,17600000000000
       Accounts payable 
0
142,232
234,277
204,260
201,242
247,407
281,428
350,455
427,044
269,212
285,319
245,139
107,385
143,128
87,938
143,404
130,417
156,764
157,613
143,212
224,073
224,073143,212157,613156,764130,417143,40487,938143,128107,385245,139285,319269,212427,044350,455281,428247,407201,242204,260234,277142,2320
       Other Current Liabilities 
0
41,369
40,619
34,110
18,697
24,985
39,667
46,765
86,326
77,536
75,817
103,036
110,982
85,929
47,106
65,969
88,789
146,147
179,992
374,957
700,016
700,016374,957179,992146,14788,78965,96947,10685,929110,982103,03675,81777,53686,32646,76539,66724,98518,69734,11040,61941,3690
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,952
55,004
124,733
140,753
240,235
244,593
90,719
90,719244,593240,235140,753124,73355,00448,95200000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,841
2,025
1,527
444
4441,5272,0252,84100000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
1,120
0
1,500
2,094
3,884
3,475
45,435
48,952
55,004
124,733
137,912
238,210
243,066
90,275
90,275243,066238,210137,912124,73355,00448,95245,4353,4753,8842,0941,50001,1200000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
15,872
15,139
18,145
24,562
34,090
61,962
125,170
170,535
216,943
0
0216,943170,535125,17061,96234,09024,56218,14515,13915,87200000000000
> Total Stockholder Equity
0
373,904
411,471
488,314
512,257
578,352
628,541
711,289
834,954
918,878
982,112
1,091,737
1,248,280
1,473,876
1,636,756
1,806,158
1,921,162
2,025,636
2,170,503
2,380,714
2,641,956
2,641,9562,380,7142,170,5032,025,6361,921,1621,806,1581,636,7561,473,8761,248,2801,091,737982,112918,878834,954711,289628,541578,352512,257488,314411,471373,9040
   Common Stock
0
84,880
84,880
84,880
84,791
84,241
82,964
83,649
84,578
84,707
84,838
84,973
85,348
85,206
84,952
84,197
84,197
82,867
81,072
80,370
80,389
80,38980,37081,07282,86784,19784,19784,95285,20685,34884,97384,83884,70784,57883,64982,96484,24184,79184,88084,88084,8800
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000-570,650-489,111-440,218-392,856-344,436-292,887-226,886-201,153-175,846-150,642-129,833-112,792000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
76,861
60,281
26,160
26,160
0
0
2,521
2,911
2,9112,5210026,16026,16060,28176,8610000000000000
   Treasury Stock00-430-16100-7400000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
2,547
179
-10,419
21,574
24,984
39,069
47,239
49,260
23,195
2,561,567
2,561,56723,19549,26047,23939,06924,98421,574-10,4191792,54700000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue1,277,682
Cost of Revenue-511,004
Gross Profit766,678766,678
 
Operating Income (+$)
Gross Profit766,678
Operating Expense-829,303
Operating Income500,684-62,625
 
Operating Expense (+$)
Research Development79,478
Selling General Administrative263,791
Selling And Marketing Expenses0
Operating Expense829,303343,269
 
Net Interest Income (+$)
Interest Income61,980
Interest Expense-22,519
Other Finance Cost-20,457
Net Interest Income19,004
 
Pretax Income (+$)
Operating Income500,684
Net Interest Income19,004
Other Non-Operating Income Expenses0
Income Before Tax (EBT)438,408500,684
EBIT - interestExpense = 387,510
440,614
380,576
Interest Expense22,519
Earnings Before Interest and Taxes (EBIT)410,029460,927
Earnings Before Interest and Taxes (EBITDA)505,189
 
After tax Income (+$)
Income Before Tax438,408
Tax Provision-82,557
Net Income From Continuing Ops355,851355,851
Net Income358,057
Net Income Applicable To Common Shares358,057
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,380
Total Other Income/Expenses Net0-19,004
 

Technical Analysis of Dawnrays
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dawnrays. The general trend of Dawnrays is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dawnrays's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dawnrays Pharmaceutical Holdings Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.16 < 1.35 < 1.35.

The bearish price targets are: 1.1643344827586 > 1.15 > 1.15.

Tweet this
Dawnrays Pharmaceutical Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dawnrays Pharmaceutical Holdings Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dawnrays Pharmaceutical Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dawnrays Pharmaceutical Holdings Ltd. The current macd is 0.01422647.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dawnrays price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dawnrays. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dawnrays price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDawnrays Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dawnrays Pharmaceutical Holdings Ltd. The current adx is 39.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dawnrays shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Dawnrays Pharmaceutical Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dawnrays Pharmaceutical Holdings Ltd. The current sar is 1.345.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dawnrays Pharmaceutical Holdings Ltd. The current rsi is 42.89. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Dawnrays Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dawnrays Pharmaceutical Holdings Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dawnrays price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dawnrays Pharmaceutical Holdings Ltd Daily Stochastic Oscillator ChartDawnrays Pharmaceutical Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dawnrays Pharmaceutical Holdings Ltd. The current cci is -105.48523207.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dawnrays Pharmaceutical Holdings Ltd. The current cmo is -28.89770558.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartDawnrays Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dawnrays Pharmaceutical Holdings Ltd. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dawnrays is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dawnrays Pharmaceutical Holdings Ltd Daily Williams %R ChartDawnrays Pharmaceutical Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dawnrays Pharmaceutical Holdings Ltd.

Dawnrays Pharmaceutical Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dawnrays Pharmaceutical Holdings Ltd. The current atr is 0.05655215.

Dawnrays Pharmaceutical Holdings Ltd Daily Average True Range (ATR) ChartDawnrays Pharmaceutical Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dawnrays Pharmaceutical Holdings Ltd. The current obv is -5,572,015.

Dawnrays Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) ChartDawnrays Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dawnrays Pharmaceutical Holdings Ltd. The current mfi is 25.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dawnrays Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dawnrays Pharmaceutical Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Dawnrays Pharmaceutical Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.888
Ma 20Greater thanMa 501.274
Ma 50Greater thanMa 1001.181
Ma 100Greater thanMa 2001.122
OpenGreater thanClose1.150
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dawnrays with someone you think should read this too:
  • Are you bullish or bearish on Dawnrays? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dawnrays? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dawnrays Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Dawnrays Pharmaceutical Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dawnrays Pharmaceutical Holdings Ltd.

Receive notifications about Dawnrays Pharmaceutical Holdings Ltd in your mailbox!